GRI

GRI Bio, Inc.

Price Chart

No historical data available

Latest Quote

$1.92

-0.15 (-7.25%)

Current Price

Previous Close	$2.07
Open	$2.05
Day High	$2.07
Day Low	$1.92
Volume	33,454

Fetched: 2026-08-30T03:07:00

Stock Information

Shares Outstanding	2.19M
Total Debt	$44K
Cash Equivalents	$10.95M
Net Income	$-9.66M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$4.20M
EPS (TTM)	$-2.83
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About GRI Bio, Inc.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

📰 Latest News

No news articles available at the moment. Check back later for updates on GRI.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Total Expenses	$11,977,000	$8,235,000	$11,387,000	$2,239,000
Net Non Operating Interest Income Expense	$21,000	$25,000	$-2,082,000	$-653,000
Operating Expense	$11,977,000	$8,235,000	$11,387,000	$2,239,000
General And Administrative Expense	$5,158,000	$4,467,000	$8,155,000	$1,997,000
Other Income Expense	-	$3,000	$432,000	$-325,000
Other Non Operating Income Expenses	-	$3,000	$432,000	-
Interest Expense	-	-	$2,082,000	$653,000
Interest Expense Non Operating	-	-	$2,082,000	$653,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Net Interest Income	$21,000	$25,000	$-2,082,000	$-653,000
Interest Income	$21,000	$25,000	-	-
Normalized Income	$-11,956,000	$-8,207,000	$-13,037,000	$-2,892,000
Net Income From Continuing And Discontinued Operation	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Total Operating Income As Reported	$-11,977,000	$-8,235,000	$-11,387,000	$-2,239,000
Net Income Common Stockholders	$-11,956,000	$-10,118,000	$-13,037,000	$-3,217,000
Net Income	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Net Income Including Noncontrolling Interests	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Net Income Continuous Operations	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Pretax Income	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Interest Income Non Operating	$21,000	$25,000	-	-
Operating Income	$-11,977,000	$-8,235,000	$-11,387,000	$-2,239,000
Special Income Charges	-	-	$0	$-325,000
Per Share
Diluted EPS	$-121.80	$-1545.55	$-125355.77	$-47308.82
Basic EPS	$-121.80	$-1545.55	$-125355.77	$-47308.82
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-11,973,000	$-8,231,000	$-10,951,000	$-2,236,000
Reconciled Depreciation	$4,000	$4,000	$4,000	$3,000
EBITDA (Bullshit earnings)	$-11,973,000	$-8,231,000	$-10,951,000	$-2,561,000
EBIT	$-11,977,000	$-8,235,000	$-10,955,000	$-2,564,000
Diluted Average Shares	$98,161	$6,546	$104	$68
Basic Average Shares	$98,161	$6,546	$104	$68
Diluted NI Availto Com Stockholders	$-11,956,000	$-10,118,000	$-13,037,000	$-3,217,000
Otherunder Preferred Stock Dividend	$0	$1,911,000	-	-
Research And Development	$6,819,000	$3,768,000	$3,232,000	$242,000
Selling General And Administration	$5,158,000	$4,467,000	$8,155,000	$1,997,000
Other Gand A	$5,158,000	$4,467,000	$8,155,000	$1,997,000
Total Unusual Items	-	-	$182,000	$-325,000
Total Unusual Items Excluding Goodwill	-	-	$182,000	$-325,000
Gain On Sale Of Security	-	-	$182,000	-
Other Special Charges	-	-	-	$325,000

Fetched: 2026-08-26

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$6,008,000	$4,032,000	$259,000	$-1,625,000
Total Assets	$8,666,000	$5,739,000	$2,956,000	$383,000
Total Non Current Assets	$74,000	$124,000	$22,000	$71,000
Current Assets	$8,592,000	$5,615,000	$2,934,000	$312,000
Other Current Assets	$363,000	$587,000	$1,126,000	$303,000
Cash Cash Equivalents And Short Term Investments	$8,229,000	$5,028,000	$1,808,000	$9,000
Cash And Cash Equivalents	$8,229,000	$5,028,000	$1,808,000	$9,000
Cash Financial	$8,229,000	$5,028,000	$1,808,000	$9,000
Non Current Prepaid Assets	-	-	-	$4,000
Debt
Total Debt	$71,000	$119,000	$14,000	$673,000
Long Term Debt And Capital Lease Obligation	$15,000	$71,000	$0	$14,000
Current Debt And Capital Lease Obligation	$56,000	$48,000	$14,000	$659,000
Net Debt	-	-	-	$593,000
Current Debt	-	-	-	$602,000
Other Current Borrowings	-	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$2,658,000	$1,707,000	$2,697,000	$2,008,000
Total Non Current Liabilities Net Minority Interest	$15,000	$71,000	$0	$14,000
Current Liabilities	$2,643,000	$1,636,000	$2,697,000	$1,994,000
Payables And Accrued Expenses	$2,587,000	$1,588,000	$2,680,000	$1,330,000
Payables	$1,837,000	$897,000	$1,410,000	$1,294,000
Accounts Payable	$1,837,000	$897,000	$1,410,000	$1,294,000
Other Current Liabilities	-	-	$3,000	-
Current Deferred Liabilities	-	-	$0	$5,000
Current Notes Payable	-	-	$0	$602,000
Interest Payable	-	-	-	$0
Equity
Common Stock Equity	$6,008,000	$4,032,000	$259,000	$-1,625,000
Total Equity Gross Minority Interest	$6,008,000	$4,032,000	$259,000	$-1,625,000
Stockholders Equity	$6,008,000	$4,032,000	$259,000	$-1,625,000
Retained Earnings	$-51,696,000	$-39,740,000	$-31,533,000	$-18,496,000
Other
Ordinary Shares Number	$497,692	$18,767	$104	$68
Share Issued	$497,692	$18,767	$104	$68
Tangible Book Value	$6,008,000	$4,032,000	$259,000	$-1,625,000
Invested Capital	$6,008,000	$4,032,000	$259,000	$-1,023,000
Working Capital	$5,949,000	$3,979,000	$237,000	$-1,682,000
Capital Lease Obligations	$71,000	$119,000	$14,000	$71,000
Total Capitalization	$6,008,000	$4,032,000	$259,000	$-1,625,000
Additional Paid In Capital	$57,704,000	$43,772,000	$31,792,000	$16,871,000
Capital Stock	$0	$0	$0	$0
Common Stock	$0	$0	$0	$0
Long Term Capital Lease Obligation	$15,000	$71,000	$0	$14,000
Current Capital Lease Obligation	$56,000	$48,000	$14,000	$57,000
Current Accrued Expenses	$750,000	$691,000	$1,270,000	$36,000
Net PPE	$74,000	$124,000	$22,000	$71,000
Accumulated Depreciation	$-34,000	$-30,000	$-26,000	$-22,000
Gross PPE	$108,000	$154,000	$48,000	$93,000
Other Properties	$71,000	$120,000	$14,000	$67,000
Machinery Furniture Equipment	$37,000	$34,000	$34,000	$26,000
Pensionand Other Post Retirement Benefit Plans Current	-	-	-	$33,000

Fetched: 2026-08-26

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-10,189,000	$-8,611,000	$-8,998,000	$-1,088,000
Operating Activities
Operating Cash Flow	$-10,186,000	$-8,611,000	$-8,990,000	$-1,085,000
Cash Flow From Continuing Operating Activities	$-10,186,000	$-8,611,000	$-8,990,000	$-1,085,000
Operating Gains Losses	-	$-3,000	$-182,000	$325,000
Investing Activities
Capital Expenditure	$-3,000	-	$-8,000	$-3,000
Investing Cash Flow	$-3,000	$0	$-8,000	$-3,000
Cash Flow From Continuing Investing Activities	$-3,000	$0	$-8,000	$-3,000
Financing Activities
Repurchase Of Capital Stock	$-1,000	$-1,000	$0	$-124,000
Issuance Of Capital Stock	$15,560,000	$13,103,000	$12,250,000	$0
Financing Cash Flow	$13,390,000	$11,831,000	$10,797,000	$1,007,000
Cash Flow From Continuing Financing Activities	$13,390,000	$11,831,000	$10,797,000	$1,007,000
Net Other Financing Charges	$-2,169,000	$-2,033,000	$-2,715,000	$-119,000
Net Common Stock Issuance	$15,559,000	$13,102,000	$12,250,000	$-124,000
Common Stock Issuance	$15,560,000	$13,103,000	$12,250,000	$0
Other
End Cash Position	$8,229,000	$5,028,000	$1,808,000	$9,000
Beginning Cash Position	$5,028,000	$1,808,000	$9,000	$90,000
Changes In Cash	$3,201,000	$3,220,000	$1,799,000	$-81,000
Proceeds From Stock Option Exercised	$0	$762,000	$12,000	$0
Common Stock Payments	$-1,000	$-1,000	$0	$-124,000
Net PPE Purchase And Sale	$-3,000	$0	$-8,000	$-3,000
Purchase Of PPE	$-3,000	$0	$-8,000	$-3,000
Change In Working Capital	$925,000	$-448,000	$1,680,000	$1,515,000
Change In Other Current Liabilities	$-48,000	$105,000	$-57,000	$-43,000
Change In Payables And Accrued Expense	$722,000	$-866,000	$2,284,000	$1,593,000
Change In Accrued Expense	$59,000	$-479,000	$125,000	$696,000
Change In Payable	$663,000	$-387,000	$2,159,000	$897,000
Change In Account Payable	$663,000	$-387,000	$2,159,000	$897,000
Change In Prepaid Assets	$251,000	$313,000	$-547,000	$-35,000
Other Non Cash Items	$48,000	$-105,000	$2,157,000	$217,000
Stock Based Compensation	$793,000	$148,000	$388,000	$25,000
Depreciation Amortization Depletion	$4,000	$4,000	$4,000	$3,000
Depreciation And Amortization	$4,000	$4,000	$4,000	$3,000
Depreciation	$4,000	$4,000	$4,000	$3,000
Net Income From Continuing Operations	$-11,956,000	$-8,207,000	$-13,037,000	$-3,217,000
Issuance Of Debt	-	$0	$1,250,000	$1,500,000
Net Issuance Payments Of Debt	-	$0	$1,250,000	$1,250,000
Net Short Term Debt Issuance	-	$0	$1,250,000	$1,250,000
Short Term Debt Issuance	-	$0	$1,250,000	$1,500,000
Gain Loss On Investment Securities	-	$-3,000	$-182,000	-
Repayment Of Debt	-	-	$0	$-250,000
Interest Paid Supplemental Data	-	-	$0	$33,000
Short Term Debt Payments	-	-	$0	$-250,000
Asset Impairment Charge	-	-	$53,000	$47,000
Net Long Term Debt Issuance	-	-	-	$1,250,000
Long Term Debt Payments	-	-	-	$-125,000
Long Term Debt Issuance	-	-	-	$1,375,000

Fetched: 2026-08-26